Postherpetic neuralgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subjects volunteered and signed the informed consent of the trial; 2. Patients aged 18 or more and less than 80 years, regardless of gender. 3. Patients with chronic herpes zoster neuralgia, and the pain site is located in the chest and abdomen; 4. Patients with moderate or severe pain but poor effect, vas > 4; 5. Patients who can objectively describe symptoms and actively cooperate.
Exclusion criteria
Exclusion criteria: 1. The patient had postherpetic neuralgia in other parts except chest and abdomen; 2. Patients with severe coagulation dysfunction; 3. Patients with severe heart, lung, liver and kidney dysfunction; 4. Patients who took other analgesics (including non steroidal anti-inflammatory drugs and opioids) in addition to the study protocol during the observation period; 5. Patients who have used drugs for the treatment of postherpetic neuralgia or used glucocorticoids and immunosuppressants within one week before enrollment; 6. Patients with local or systemic infection by puncture; 7. Patients with diabetes history > 5 years and blood glucose control not reaching the normal value (fasting blood glucose > 8 mmol / L, 2 h postprandial blood glucose > 10 mmol / L); 8. Patients who are allergic to known ingredients of the test drug; 9. Non lactating and pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale;Quality of Sleep, QS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total dosage of tramadol sustained release tablets;adverse reaction; | — |
Countries
China
Contacts
The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China (USTC)